1.
|
Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PROLOGUE-EFC4978, UCLA-0403071-01, NCT00230178
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-D82-051-605
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-81001, NCI-D82-018-0400, D82-018-0400
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: EST-2483
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GI-82389
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 2 to 21
Sponsor: NCI
Protocol IDs: CCG-782
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-82-C-199, NCI-POB-7709, NCI-T83-0966N, T83-0966
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-191, NCI-82-C-200, NCI-POB-7702
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: EST-1484
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 50
Sponsor:
Protocol IDs: FHCRC-122, NCI-V83-0098
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: FHCRC-84, NCI-V83-0094
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCCRC-2121B, NCI-V83-0124
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: EST-3483
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: EST-5483
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: DFCI-84010, NCI-T84-0245D, T84-0245
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: SEG-ALL-304
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: CCG-123
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 20
Sponsor:
Protocol IDs: YALE-HIC-3333, NCI-V84-0064
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor:
Protocol IDs: LAC-USC-13NHL851, NCI-V85-0216
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 50
Sponsor:
Protocol IDs: UCSF-ANL-03, NCI-V85-0175
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: AECM-8509199, NCI-V86-0029
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI
Protocol IDs: COG-8651, NCI-87-C-68A, NCI-T87-0134N, POG-8651
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8691, EST-7486, CALGB-8691
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor: NCI
Protocol IDs: EST-3486
|
Mobile | Español
